Gerardo Del Real and Nick Hodge DepartureReceived emails on Friday (10/17) that Del Real (Junior Mining Monthly / Trader) and Nick Hodge (Wallstreet Underground Profits) both from the The Outsider Club newsletter had abruptly left The Outside Club for “greener pastures”. Another email referring to Del Real state his departure was under “a disappointing string of events”. The Outsider Club (Angel Publishing) is shutting down both WSUP and JMM to replace with a new newsletter Wallstreet Proving Ground. They found a new editor for JMT. Nick was co-founder of the Outsider Club. I would like to know if anyone knows about this and / or the circumstances involved. Thank you.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Interesting, I hadn’t noticed that news yet — thanks for sharing.
It appears that they have moved to something they’re calling Resource Stock Digest, which both has some “premium” letters that those two and another couple analysts will be helping, and a “sponsorship” of some sort whereby companies can buy coverage or exposure on the site. Looks kind of iffy to me, but who knows, we’ll see how it goes (and what kind of stocks they end up teasing).
No idea whether they left voluntarily to start this or just wore out their subscriber base, as happens sometimes, and needed a fresh start… or just wanted to accept money from companies or otherwise have more freedom than the Agora agreements might allow (or maybe this latest outfit is another Agora-affiliated publisher, I don’t know — if so, they don’t acknowledge it). Folks who loved them will have to follow them to their new site and pay anew, I have no idea whether the Outsider Club is offering any compensation for the end of those publications — both Hodge and Del Real have free sample issues up of the letters they’re launching, so it sounds like they’re still picking the same kinds of stocks (and exactly the same stocks, in many cases), so I’d guess those letters will be similar to what previous subscribers are used to. I’ll keep an eye out for any hype-y pitches those two throw, thanks for the update.
Just looked at their new website and they have over 40 sponsored companies (all gold and silver except at least one rare coin co.) Most of the sponsors are stocks that were in their portfolios before and probably the new ones too. That makes me nervous for possible paid sponsors from the stocks they recommend. I’m done with both of them and soon The Outsider Club
Thanks for information Travis!!!
Accepting paid sponsorships by companies is a slippery slope in the investing world, in my experience. Legal if you disclose it, and still pretty common in some parts, particularly in the natural resources world where I think many investors expect everyone involved to be a scoundrel to some degree… but it immediately drops you down a rung when it comes to saying you’re doing any critical thinking about those companies.
Nick Hodge–not all gold resource companies. Lexagene on verge of commericialization. Vet sales first up.
ttps://www.resourcestockdigest.com/archives/market-commentary/sample-issue-nick-hodges-family-office-advantage/
LexaGene Holdings (TSX-V: LXG)(OTC: LXXGF) was dealing with supply chain delays for parts for its MiQLab. Those are now resolved and the company is testing and optimizing it ahead of sales, and has given early access to key leaders in the markets it hopes to sell its pathogen detection system. There is also a delay in getting the device approved by the FDA for COVID-19 testing, with the study now expected to start in December. LexaGene is cashed up with C$14.9 million in the bank. The share pullback related to the dely presents an opportunity, in that, like ImmunoPrecise, COVID-19 testing was never LexaGene’s goal. It’s the vet and food markets where it can make serious sales. It’s a buy under C$1.00.
Cleveland, I’m curious if you personally think it’s a buy at these levels (under C$1.00)?
Take a look at Lexagene now. Stock has exploded and yes it is still undervalued with incredible potential.
i for one am extremely pissed that they split with no warning or explanation at such a crucial time.